NAGE Cash & Equivalents
Niagen Bioscience Inc · Cash & Equivalents
NAGE Cash & Equivalents
Latest reported$64.79Mperiod ending
NAGE FY Cash & Equivalents ($580.00 → $64.79M)
Annual Cash & Equivalents
High-resolution chart · PNG
NAGE cash & equivalents history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cash & Equivalents (USD) |
|---|---|
| 64,788,000 | |
| 44,508,000 | |
| 27,173,000 | |
| 20,289,000 | |
| 28,019,000 | |
| 16,497,000 | |
| 18,612,000 | |
| 22,416,000 | |
| 45,389,000 | |
| 1,642,429 | |
| 5,549,672 | |
| 3,964,750 | |
| 2,261,336 | |
| 520,000 | |
| 420,152 | |
| 2,226,459 | |
| 471,378 | |
| 1,125,504 | |
| 580 |